EDWARD SZTEINBAUM
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry PRINCETON, NJ NPI 1063506293
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NJ Supernus Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$245.43
- Category: General Payments
- Program years: PY2018–2022
- Record count: 15
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $104.49 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $104.49 | 7 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | $47.34 | 3 |
| ITI, Inc. | $31.99 | 2 |
| Lundbeck LLC | $13.17 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $11.99 | 1 |
By program year
Records — PY2022 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 945728711 | ITI, Inc. | $15.68 | 01/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 945728715 | ITI, Inc. | $16.31 | 02/23/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 945807699 | Lundbeck LLC | $13.17 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953023221 | Supernus Pharmaceuticals, Inc. | $14.36 | 10/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953023223 | Supernus Pharmaceuticals, Inc. | $15.49 | 11/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 953023225 | Supernus Pharmaceuticals, Inc. | $17.49 | 12/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 956167179 | Takeda Pharmaceuticals U.S.A., Inc. | $11.99 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.